Improved high-performance liquid chromatographic assay for the quantification of 5-bromo-2′-deoxyuridine and 5-bromouracil in plasma

This publication has 15 references indexed in Scilit:

• Halogenated Pyrimidines as Radiosensitizers in the Treatment of Glioblastoma Multiforme
  American Journal of Clinical Oncology, 1987
• Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors
  Journal of Neurosurgery, 1986
• A monoclonal antibody reactive with 5‐bromo‐2‐deoxyuridine that does not require DNA denaturation
  Cytometry, 1985
• Characterization of monoclonal antibodies to bromodeoxyuridine
  Cytometry, 1985
• Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine
  Cytometry, 1985
• Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma
  International Journal of Radiation Oncology*Biology*Physics, 1985
• Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication
  Science, 1982
• GENETICS OF HUMAN CELL LINES
  The Journal of Experimental Medicine, 1960